Novel anti-rheumatic therapies challenge old views on ankylosing spondylitis and other spondyloarthritides
Braun, J.; van der Heijde, D.; Pincus, T.
Clinical and Experimental Rheumatology 20(6 Suppl 28: S1-S2
2002
ISSN/ISBN: 0392-856X PMID: 12463437 Document Number: 545971
Document emailed within 1 workday
Related Documents
Papagoras, C.; Voulgari, P.V.; Drosos, A.A. 2013: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis Clinical and Experimental Rheumatology 31(4): 612-620Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Veys, E.M.; Verbruggen, G.; Hermanns, P.; Mielants, H.; Van Bruwaene, P.; De Brabanter, G.; De Landsheere, D.; Immesoete, C. 1983: Peripheral blood T lymphocytes subpopulations in HLA-B7 related rheumatic diseases: ankylosing spondylitis and reactive synovitis Journal of Rheumatology 10(1): 140-143
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Doury, P.; Pattin, S. 1980: Anti-inflammatory treatment of ankylosing spondylitis La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 56(1-2): 89-91
Rabinowicz, T.; Jacqueline, F. 1980: Lesions of the nerves of the hip involving chronic rheumatic infections (ankylosing spondylitis, rheumatoid arthritis, arthrosis). Anatomopathologic study Revue du Rhumatisme et des Maladies Osteo-Articulaires 47(1): 37-44
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Yuan, G.; Shi, G.; Ding, Y. 1995: Serum anti-subtypical Klebsiella pneumoniae antibodies in ankylosing spondylitis Zhonghua Nei Ke Za Zhi 34(3): 193-195
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Chen, C.S.; Shi, G.Y. 1994: Detection of serum anti-histone antibodies in patients with ankylosing spondylitis and its clinical significance Zhonghua Nei Ke Za Zhi 33(6): 382-384
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Zochling, J.; Sieper, J.; van der Heijde, Désirée.; Braun, Jürgen.; Weber, U.; Rudwaleit, M.; Leirisalo-Repo, M.; Collantes-Estévez, E.; van der Horst-Bruinsma, I.; Géher, P.; Kvien, T.; deVlam, K.; l Ostergaard, M.; Maksymowych, W. 2008: Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy Journal of Rheumatology 35(6): 1079-1082
Shu, T.; Chen, G.H.; Rong, L.; Feng, F.; Yang, B.; Chen, R.; Wang, J. 2013: Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials Clinical and Experimental Rheumatology 31(5): 717-722
Braun, J.; Sieper, J. 2002: Anti-TNF therapy and the spondyloarthritides: who should be treated? Clinical and Experimental Rheumatology 20(6 Suppl 28: S187
Padmavati, S. 1982: The challenge of rheumatic fever and rheumatic heart disease in India Indian Heart Journal 34(6): 364-366
Jajić, Z. 2000: Ankylosing spondylitis Reumatizam 47(2): 18-19
Costa, T.; Falcão, S.; Mateus, M.; Branco, J. 2018: More than Ankylosing Spondylitis Acta Reumatologica Portuguesa 2018
Saraux, A. 2011: Ankylosing spondylitis La Revue du Praticien 61(7): 999-1006